How will the two-weeks-wait rule affect delays in management of urological cancers?
Open Access
- 31 July 2003
- journal article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 96 (8) , 398-399
- https://doi.org/10.1258/jrsm.96.8.398
Abstract
The UK National Health Service has now specified a maximum interval of two weeks between general practitioner (GP) referral and specialist assessment for patients with suspected cancer. We examined progress through the cancer pathway in 160 patients with potentially curable cancers of the prostate, bladder, kidney and testis before implementation of this rule. Median intervals with interquartile ranges were quantified from the first GP consultation to hospital referral, then to the first hospital consultation, confirmation of diagnosis and definitive surgery.Keywords
This publication has 12 references indexed in Scilit:
- Delay and survival in bladder cancerBJU International, 2002
- Factors involved in diagnostic delay of testicular cancer.International Urology and Nephrology, 1999
- Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment.BMJ, 1991
- Delays in diagnosing and treating bladder cancerBMJ, 1988
- Treatment delay in patients with bladder tumours.Journal of Epidemiology and Community Health, 1985
- Factors contributing to delay in diagnosis of testicular tumours.BMJ, 1985
- Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.1985
- Presenting Symptoms, Treatment Delay and Survival in Bladder CancerScandinavian Journal of Urology and Nephrology, 1983
- A haematuria diagnostic service.BMJ, 1977
- DELAY IN TREATING BLADDER TUMOURSThe Lancet, 1965